---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-267053"
form_type: "8-K"
ticker: "IQV"
cik: "0001478242"
company_name: "IQVIA HOLDINGS INC."
filed_at: "2025-11-05T23:59:59+00:00"
generated_at: "2026-05-17T00:14:58.283097+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nobel laureate Dr. William G. Kaelin Jr. appointed to IQVIA board

## Summary
- Appointment effective November 5, 2025.
- Kaelin awarded 2019 Nobel Prize in Physiology or Medicine for oxygen-sensing and VHL tumor suppressor work.
- Senior physician-scientist at Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School.
- Also serves on Eli Lilly board and chairs its Science and Technology Committee.
- Board determined Kaelin meets NYSE independence standards.

## SEC filing metadata
- accession: 0001193125-25-267053
- form_type: 8-K
- ticker: IQV
- cik: 0001478242
- company_name: IQVIA HOLDINGS INC.
- filed_at: 2025-11-05T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1478242/000119312525267053/0001193125-25-267053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1478242/000119312525267053/d89736d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-267053
- JSON: https://secwatch.observer/filing/0001193125-25-267053.json
- Plain text: https://secwatch.observer/filing/0001193125-25-267053.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.